HOME
The Info List - British Approved Name


--- Advertisement ---



A British Approved Name (BAN) is the official non-proprietary or generic name given to a pharmaceutical substance, as defined in the British Pharmacopoeia (BP). The BAN is also the official name used in some countries across the world, because starting in 1953, proposed new names were evaluated by a panel of experts from WHO in conjunction with the BP commission to ensure naming consistency worldwide[1] (an effort leading to the International Nonproprietary Name system).

Contents

1 Combination preparations 2 BAN harmonisation 3 See also 4 References

Combination preparations[edit] BANs are unique in that names are assigned for combination preparations as well as single-drug preparations. For example, the BAN Co-amoxiclav
Co-amoxiclav
is assigned to preparations containing amoxicillin and clavulanic acid. Most other pharmacopoeias simply refer to combination products by both ingredients in the preparation, in this example "amoxicillin with clavulanic acid". The prefix of "co-" is used for many combination drugs, including opioid with paracetamol or aspirin analgesics (e.g., Co-codamol, Co-codaprin, Co-dydramol, Co-proxamol). The other commonly encountered opioid combination is the anti-diarrhoeal, non-analgesic mixture of diphenoxylate and atropine, Co-phenotrope (a.k.a. Lomotil). Also antibiotics (e.g., Co-fluampicil and Co-trimoxazole), drugs to lower blood pressure (e.g., Co-tenidone), diuretics (e.g., Co-amilofruse
Co-amilofruse
and Co-amilozide), gastrointestinal drugs (e.g., Co-danthrusate), and anti- Parkinsonism agents such as Co-careldopa, Co-beneldopa, and others (e.g., Co-cyprindiol). BAN harmonisation[edit] European Union
European Union
legislation from 2001 required harmonisation of the BP with the European Pharmacopoeia
European Pharmacopoeia
(EP), as well as the adoption of International Nonproprietary Names through directives (2001/82/EC [2] and 2001/83/EC,[3] as amended, and 2003/63/EC [4]). Across the EU has meant that, with the notable exception of adrenaline/epinephrine,[5] BANs are now the same as the INNs. For example, the old BAN methicillin was replaced with the current BAN meticillin, matching the INN. This has resulted in an interesting situation in other countries that use BANs. While the British Pharmacopoeia and BANs are the official pharmacopoeia/names defined by legislation in many of these countries, the former BANs often continue to be used, purportedly because of the difficulty of changeover. Despite the importance of the BP, there appears to be little or no movement in the direction of changing these names. In Australia, the Australian Approved Names are generally the same as BANs, but a few exceptions remain. See also[edit]

International English food terms Nomenclature United States Adopted Name British Pharmacopoeia

References[edit]

^ Mr Anthony C Cartwright (28 June 2015). The British Pharmacopoeia, 1864 to 2014: Medicines, International Standards and the State. Ashgate Publishing, Ltd. pp. 155–. ISBN 978-1-4724-2032-9.  ^ "2001/82/EC" ^ "2001/83/EC" ^ "2003/63/EC" ^ Aronson, JK (19 February 2000). ""Where name and image meet"--the argument for "adrenaline"". BMJ (Clinical research ed.). 320 (7233): 506–9. doi:10.1136/bmj.320.7233.506. PMC 1127537 . PMID 10678871. 

v t e

Pharmaceutical
Pharmaceutical
and biotechnology industry in the United Kingdom

Manufacturing in the United Kingdom Economy of the United Kingdom

companies

current

AAH Pharmaceuticals Alliance Boots Astex AstraZeneca
AstraZeneca
(MedImmune) BTG Cyclacel Dechra Pharmaceuticals GE Healthcare Genus GlaxoSmithKline Hikma Pharmaceuticals Indivior MacFarlan Smith Norbrook Group Oxford BioMedica Pfizer UK Phytopharm Proximagen Shire Silence Therapeutics TBS GB Unipath Vectura Group Vernalis ViiV Healthcare

defunct

Allen & Hanburys Amersham Beecham Group Cambridge Antibody Technology Celltech Chiroscience Distillers Company Fisons Glaxo Wellcome ICI Reliant Pharmaceuticals Renovo Zeneca

government and regulatory bodies

Commission on Human Medicines Department of Health European Directorate for the Quality of Medicines European Medicines Agency Medicines and Healthcare Products Regulatory Agency National Collaborating Centre for Mental Health National Patient Safety Agency Pharmaceutical
Pharmaceutical
Price Regulation Scheme Pharmaceutical
Pharmaceutical
Society of Northern Ireland General Pharmaceutical
Pharmaceutical
Council Scottish Medicines Consortium Veterinary Medicines Directorate

industry and professional bodies

Association of the British Pharmaceutical
Pharmaceutical
Industry Chemical Industries Association European Federation of Biotechnology European Federation of Pharmaceutical
Pharmaceutical
Industries and Associations Faculty of Pharmaceutical
Pharmaceutical
Medicine Pharmacists' Defence Association Royal Pharmaceutical
Pharmaceutical
Society of Great Britain Worshipful Society of Apothecaries

books and journals

Bandolier Bad Pharma
Bad Pharma
(2012) British National Formulary British National Formulary
British National Formulary
for Children Monthly Index of Medical Specialities Side Effects (2008) The Pharmaceutical
Pharmaceutical
Journal

other

British Approved Name British Pharmacopoeia DrugScope European and Developing Countries Clinical Trials Partnership European Pharmacopoeia List of world's largest pharmaceutical companies Pharmaceutical
Pharmaceutical
Services Negotiating Committee Wellcome Tru

.